Sydney, Aug. 07, 2025 (GLOBE NEWSWIRE) — Pacific Green Technologies, Inc., a global leader in battery energy storage solutions, is pleased to announce that its Australian battery storage business has signed a [...] Read more »
Erste „Klimabürger“ von Nauru im weltweit ersten Programm zugelassen
AUCKLAND, Neuseeland, Aug. 05, 2025 (GLOBE NEWSWIRE) — Die Republik Nauru hat ihre ersten neuen Staatsbürger im Rahmen des Regierungsprogramms „Economic and Climate Resilience Citizenship Program” (Programm für [...] Read more »
Nauru accueille ses premiers citoyens du climat dans le cadre d’un programme inédit dans le monde
AUCKLAND, Nouvelle–Zélande, 05 août 2025 (GLOBE NEWSWIRE) — La république de Nauru a accueilli ses premiers nouveaux citoyens dans le cadre de l’Economic and Climate Resilience Citizenship Program [...] Read more »
Primeiros “cidadãos do clima” aprovados por Nauru em programa inédito no mundo
AUCKLAND, Nova Zelândia, Aug. 05, 2025 (GLOBE NEWSWIRE) — A República de Nauru deu as boas–vindas aos seus primeiros novos cidadãos no âmbito do Programa de Cidadania de Resiliência [...] Read more »
Pacific Green Signs Commitment Agreement With ZEN Energy for BESS Offtake in Australia for 1.5GWh
Sydney, Aug. 05, 2025 (GLOBE NEWSWIRE) — – Pacific Green is pleased to announce that its battery energy storage business in Australia has entered into a commitment agreement with ZEN Energy [...] Read more »
First ‘climate citizens’ approved by Nauru in world-first program
AUCKLAND, New Zealand, Aug. 04, 2025 (GLOBE NEWSWIRE) — The Republic of Nauru has welcomed its first new citizens under the government’s Economic and Climate Resilience Citizenship Program, announced at COP29 late last [...] Read more »
Dr. Falk Pharma und Allianthera (Suzhou) Biopharmaceuticals gehen strategische Partnerschaft für die Entwicklung eines neuartigen AhR-Agonisten ein
Freiburg (Deutschland), Suzhou (China) und Boston (USA), 30. Juli 2025:
Dr. Falk Pharma GmbH und Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. geben strategische Partnerschaft für die Entwicklung eines [...] Read more »
Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development
Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025:
Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the [...] Read more »
Information on the total number of voting rights and shares
REGULATED INFORMATION
Information on the total number of voting rights and shares
Mont–Saint–Guibert [...] Read more »
Informations sur le nombre total de droits de vote et d'actions
INFORMATION RÉGLEMENTÉE
Informations sur le nombre total de droits de vote et d'actions
Mont–Saint–Guibert [...] Read more »